FDA Inspection
Octapharma Plasma, Inc.Octapharma Plasma, Inc. – FDA Inspection, Jan 31, 2020
Record Details
This FDA Inspection record concerns Octapharma Plasma, Inc., with an inspection on January 31, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Octapharma Plasma, Inc.
- Inspection Date
- January 31, 2020
- Product Type
- Biologics
View Company Profile
ID · 3fc4f930-9b90-405f-a48f-07f1ab7e91cd
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1117911
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Octapharma Plasma, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 25, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Octapharma Plasma, Inc.
- FDA Inspection 999141 - 2017-01-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.